Polyomavirus antiviral therapy - Orthogon Therapeutics
Alternative Names: BK virus antiviral therapy - Orthogon TherapeuticsLatest Information Update: 16 Nov 2021
At a glance
- Originator Orthogon Therapeutics
- Class Antivirals; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Polyomavirus infections
Highest Development Phases
- Preclinical Polyomavirus infections